John W. Wizeman, Ph.D.
Dr. John Wizeman is a technical specialist in the Lathrop GPM Intellectual Property practice, focusing his efforts on biotechnology and life sciences.
John has been working at Lathrop GPM for four years, with a focus on antibodies and fusion proteins, including bispecific/multispecific antibodies and chimeric extended half-life fusion proteins. John has experience in multi-jurisdictional portfolio management, including SPC protection. In addition, John was a postdoctoral researcher at the University of Connecticut Health Center where he designed and conducted single-cell RNA sequencing experiments and led analysis of results using groundbreaking programming tools and developing analytical pipelines in the neuroscience field.
- March 20, 2023
- March 17, 2022
Boston28 State StreetSuite 700Boston, MA 02109
The University of Connecticut Health Center, Ph.D. Neuroscience, 2016
Saint Michael's College, B.S. Biology, 2008